HOME >> BIOLOGY >> NEWS
A relative of smallpox is first virus found to invade cells as HIV does

As debate continues on whether to destroy the world's last two vials of smallpox virus, scientists have discovered that a virus related to smallpox uses the same route of entry as HIV to invade its host. This is the first virus other than HIV known to exploit structures called chemokine receptors on the surface of immune cells. Its discovery strengthens a new theory on the origins of a rare, life-saving immunity to the AIDS virus.

Like HIV, the myxoma poxvirus -- a pathogen that causes a rapid AIDS-like immune deficiency in rabbits -- hones in on chemokine receptors called CCR5 and CXCR4, reports a research team led by a UC San Francisco scientist. The research is published in the December 3 issue of Science.

Both viruses can dock with CCR5 or CXCR4 for successful invasion, although the scientists don't yet know if the poxvirus exploits another portal known as the CD4 receptor, as HIV does.

Linking CCR5 to an aggressive relative of smallpox strengthens an intriguing theory about the origins of a rare immunity to the HIV virus, so far found only in a small percentage of Caucasians. A mutation in one of the genes for the CCR5 receptor has recently been identified as the strongest source of this protective trait in HIV-resistant people.

Genetic analysis has traced the likely emergence of the mutation to a major epidemic about 700 years ago - possibly the European smallpox plague.

"The protective mutation in the CCR5 chemokine receptor gene almost certainly emerged well before HIV began to infect humans - just about 50 years," said Alshad Lalani, PhD, a post-doctoral researcher at UC San Francisco and lead author of the report on the poxvirus/CCR5 finding. Senior author is Grant McFadden, PhD, professor of microbiology and immunology at the University of Western Ontario and a scientist of the Robarts Research Institute.

"HIV researchers have deduced that the CCR5 mutation probably evolved at least 700 years
'"/>

Contact: Wallace Raven
wravven@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
1-Dec-1999


Page: 1 2 3 4

Related biology news :

1. Research on relative species abundance provides new theoretical foundation
2. Bacterium and puffer fish may share distant relative
3. Researchers find closest living relative of first land plants
4. Childrens Hospital Boston receives more than $10 million to help make smallpox vaccine safer
5. Report outlines steps needed to lessen smallpox threat
6. Susceptibility of mice to mousepox offers promise of smallpox protection
7. The search for a safer smallpox vaccine: New data released on promising candidate
8. NIH awards $20.7 million to make smallpox vaccine safer
9. First time in the U.S.: Saint Louis University tests third-generation vaccine against smallpox
10. Experimental smallpox DNA vaccine protects primates from lethal monkeypox
11. Experimental smallpox vaccine protects against monkeypox in nonhuman primates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
(Date:3/31/2016)... , March 31, 2016  Genomics firm Nabsys ... founding CEO, Barrett Bready , M.D., who returned ... of the original technical leadership team, including Chief Technology ... of Product Development, Steve Nurnberg and Vice President of ... to the company. Dr. Bready served as ...
(Date:3/23/2016)... , March 23, 2016 ... erhöhter Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender ... das Unternehmen mit SpeechPro zusammenarbeitet, um erstmals ... Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im Rahmen ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... on quality, regulatory and technical consulting, provides a free webinar on ... on July 13, 2016 at 12pm CT at no charge. , Incomplete investigations ...
Breaking Biology Technology:
Cached News: